Digitalizing supply chains

Improving access to vaccines through digital technologies

UNDP supports governments to harness the power of technology to digitalize national logistic management information systems (eLMIS) for improved storage, delivery and access to vaccines, medicines and other health products.

In India, UNDP is supporting the Ministry of Health and Family Welfare to digitalize vaccine supply chains with mobile technology. India is transforming the way vaccines are delivered to people, including vulnerable and migrant populations, for COVID-19 and the world’s largest universal immunization programme.

Electronic Vaccine Intelligence Network (eVIN)

eVIN is a smartphone and cloud technology-based app that digitizes information on vaccine supplies across India. Developed with support from Gavi, the Vaccine Alliance, eVIN enables vaccine handlers to report on available stocks, consumption levels and movement. It also has a SIM-enabled temperature logger for remote monitoring of storage temperatures, which are kept lower to preserve vaccines.

Data is stored in a cloud server that provides web-based dashboards and data analytics for programme managers and policymakers to view the information in real-time. This end-to-end visibility of key supply chain data allows stakeholders to effectively manage supplies and make decisions that ensure quality vaccines reach people on time.

COVID-19 Vaccine Intelligence Network (CoWIN)

The success of eVIN enabled India’s government to rapidly deploy CoWIN during the height of the COVID-19 pandemic. CoWIN was the country’s digital COVID-19 platform, which enabled patients to book appointments for vaccination and receive their vaccine certificates. It also provided vaccinators with a platform to manage vaccination sessions, develop reports and monitor progress, while allowing programme managers to monitor vaccine utilization, coverage and wastage throughout the system.
UNDP provided technical and implementation support for CoWIN. CoWIN reached more than 950 million people and enabled the expansion of vaccine coverage, including adolescents between 15 and 17 years. It registered over 36 million new beneficiaries and has supported the provision of a third vaccine dose to people above the age of 60, health workers and frontline workers.